Futura Medical plc, a pharmaceutical company focused on sexual health and pain relief products, has applied to AIM to extend its existing block listing by 10,590,675 ordinary shares. These shares will be issued from time to time as part of the Company's Long-Term Incentive Plan (LTIP). The increased block listing is expected to become effective on November 3, 2023. Futura Medical will provide six-monthly announcements regarding the utilization of the block admission, in accordance with AIM Rule 29. At present, the Company has 300,977,293 ordinary shares in issue, each carrying one voting right. The total number of voting rights in the Company is therefore 300,977,293.